Vyxeos Injection, Powder, Lyophilized, For Suspension
Product Images NDC 68727-745

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Vyxeos (NDC 68727-745). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Jazz Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carton (Image 01)

The unfolded carton label for VYXEOS injection, powder, lyophilized, for suspension, displays the proprietary name and generic names (daunorubicin and cytarabine) liposome for injection. The strength is 44 mg/100 mg per vial, with directions for intravenous infusion only. The label includes storage instructions, active and inactive ingredients, barcode, and the Jazz Pharmaceuticals, Inc. logo and contact information. The carton contains two sterile single-dose vials and cautions against interchange with other drugs containing daunorubicin or cytarabine.*

FDA Label Image

Daunorubicin (Image 02)

Chemical structure diagram of daunorubicin, one of the active ingredients in VYXEOS (daunorubicin and cytarabine) liposome injection powder. The structure shows the molecular arrangement including rings, hydroxyl groups, and amino moieties characteristic of daunorubicin.*

FDA Label Image

Cytarabine (Image 03)

Chemical structure diagram of a nucleoside compound, showing rings with nitrogen, oxygen, and hydrogen atoms attached. This likely represents part of the active ingredients in VYXEOS (daunorubicin and cytarabine) liposome.*

FDA Label Image

Kaplan-meier Curve (Image 04)

A Kaplan-Meier survival curve chart comparing VYXEOS injection with a 7+3 chemotherapy regimen over 36 months from randomization. The vertical axis represents survival percentage, and the horizontal axis shows time in months. The chart includes event/sample size data and median survival times with 95% confidence intervals for both groups.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.